Apyx Medical (APYX) Gross Profit (2011 - 2026)

Apyx Medical has reported Gross Profit for 16 years, with the latest figure at $7.9 million in Q1 2026.

• For the quarter ending Q1 2026, Gross Profit rose 39.89% year-over-year to $7.9 million; the trailing twelve-month figure through Mar 2026 stood at $35.3 million (up 21.42% YoY), and the FY2025 full-year result was $33.0 million, up 12.55% from the prior year.
• Gross Profit for Q1 2026 stood at $7.9 million, down from $12.0 million in the prior quarter.
• The five-year high for Gross Profit was $12.0 million in Q4 2025, with the low at $5.7 million in Q1 2025.
• Historically, Gross Profit has averaged $7.8 million across 5 years, with a median of $7.9 million in 2026.
• The largest YoY upside for Gross Profit was 40.26% in 2022 against a maximum downside of 32.18% in 2022.
• Apyx Medical's Gross Profit stood at $8.2 million in 2022, then advanced by 8.35% to $8.9 million in 2023, then advanced by 0.39% to $9.0 million in 2024, then surged by 33.86% to $12.0 million in 2025, then plunged by 33.95% to $7.9 million in 2026.
• The last three Gross Profit figures came in at $7.9 million (Q1 2026), $12.0 million (Q4 2025), and $8.3 million (Q3 2025), per Business Quant data.